By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sigma-Aldrich said after the close of the market Tuesday that it has completed the acquisition of BioReliance Holdings for $350 million in cash.

It purchased the firm from Avista Capital Partners, which had acquired BioReliance nearly five years ago from Invitrogen, now part of Life Technologies, for $210 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.